| 1 Frei E,Clark,JR.,Miller D.The conceptor neoadjuvant chemotherapy.In SE(ed): Adjuvant therapy of cancer.Volv.Or lando,FL:Grune& Stratton,1987.67.
2 Goldie JH,Goldman AJ.Amathematical model for relating the drag sensitivity of tumors to their spontaneous mutationrate[J].Cancer Ther Rep,1979, 63(11-12):1727-33.
3 Fisher B,Brown A,Mamounas E,et al.Effect of preoperative chemotherapy on local regional disease in women with operable breast cancer:finding from national surgical adjuvant breast and bowel project B-18[J].J Clin Oncol,1997,15:2483-93.
4 Maloisel F,Dufour P,Bergerat P,et al.Results of initial doxorubicin,5 fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast[J].Cancer,1990,65:851-855.
5 Chang J,Ormerod M,Powles TJ,et al.Apoptosis and proliferation as predictors of chemotherapy,response in patients with breast caicinoma[J].Cancer,2000,89: 2145-52.
6 Juric G,Zarkovic N,Nola M,et al.The value of cell proliferation and angiogenesis in the prognostic assessment of ovariangranulosa cell tumors[J].Tumor,2001, 879(1):47-53.
7 Lee J K,Hurwitz J.Processive DNA helicase activity of the minichromosome maintenance protein 4,6,and 7 complex requires forked DNA structures[J].Proc Natl Acad Sci USA,2001,98(1):54-59.
8 Bailis JM,Forsburg SL.MCM protein;DNA damage,mutagenesis and repair[J]. Curr Opin in Genet Dev,2004,14:17-21.
9 Freeman A,Morris IS,Mills AD,et al.Minichromosome maintenance proteins as biologicam arkers of dysplasia and malignancy[J].Clin Cancer Res,1999, 5(8):2121-32.
10 Tachibana KE,Gonzalez MA,Coleman N.Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology[J].J Pathol,2005,205 (2):123-129.
11 Gonzalez MA,Pinder SE,Callagy G,et al.Minichromosome maintenance protein 2 is astrong independent prognostic marker in breast cancer[J].J Clin Oncol, 2003,21(23):4306-13. |
